金城医药：关于子公司收到原料药CEP证书的公告

Core Viewpoint - The company announced that its wholly-owned subsidiary, Shandong Jincheng Biopharmaceutical Co., Ltd., has received the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines (EDQM) for glutathione active pharmaceutical ingredient [1] Group 1 - The CEP certificate indicates that the glutathione product meets the European Pharmacopoeia standards, which is crucial for market access in Europe [1] - This approval may enhance the company's competitive position in the biopharmaceutical market, particularly in Europe [1] - The receipt of the CEP certificate is expected to facilitate the company's export activities and potentially increase revenue from international markets [1]